MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹10,260 Cr | ₹874,943 Cr | ₹7,782 Cr | ₹621 Cr | ₹58,719 Cr |
What is the latest Revenue of MANKIND PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹10,260 Cr |
| Mar2024 | ₹874,943 Cr |
| Mar2023 | ₹7,782 Cr |
| Mar2022 | ₹621 Cr |
| Mar2021 | ₹58,719 Cr |
How is Revenue of MANKIND PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹10,260 Cr | -98.83 | |
| Mar2024 | ₹874,943 Cr | 11,143.81 | |
| Mar2023 | ₹7,782 Cr | 1,152.18 | |
| Mar2022 | ₹621 Cr | -98.94 | |
| Mar2021 | ₹58,719 Cr | - | |
Compare Revenue of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹104,912.3 Cr | 1.8% | 6.7% | 8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.8% |
6.7% |
8% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses